Anti-MOG Antibody (A14694) | Antibodies.com
Treatment Approaches for MOG-Ab-Associated Demyelination in Children | SpringerLink
Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease: practical considerations | Practical Neurology
.webp "Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Test in Delhi, NCR | GDIC")
Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Test in Delhi, NCR | GDIC
E.U. paediatric MOG consortium consensus: Part 1 – Classification of clinical phenotypes of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders - ScienceDirect
Identification of a pathogenic antibody response to native myelin oligodendrocyte glycoprotein in multiple sclerosis | PNAS
Frontiers | Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disorders: Toward a New Spectrum of Inflammatory Demyelinating CNS Disorders?
Anti-MOG encephalitis mimicking small vessel CNS vasculitis | Neurology Neuroimmunology & Neuroinflammation
Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease: practical considerations | Practical Neurology
What is MOGAD? | MOG Antibody Disease | SRNA
Review of literature on anti-MOG antibodies in adult NMO/NMOSD | Download Table
Anti-MOG Antibody Test Identifies Atypical Features, Prognosis in MS - Neurology Advisor
Spectrum of MOG antibody-associated disorders. | Download Scientific Diagram
Anti-MOG autoantibodies pathogenicity in children and macaques demyelinating diseases | Journal of Neuroinflammation | Full Text
Myelin-oligodendrocyte glycoprotein antibody-associated disease - The Lancet Neurology
Recent developments in MOG-IgG associated neurological disorders - Harald Hegen, Markus Reindl, 2020
Two of 23 MOG-Ab-positive patients were diagnosed with MS compared to... | Download Scientific Diagram
Does MOG Ig-positive AQP4-seronegative opticospinal inflammatory disease justify a diagnosis of NMO spectrum disorder? | Neurology Neuroimmunology & Neuroinflammation
Neurological update: MOG antibody disease | SpringerLink
Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease: practical considerations | Practical Neurology
IJMS | Free Full-Text | Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: Current Insights into the Disease Pathophysiology, Diagnosis and Management
JCI Insight - Siponimod therapy implicates Th17 cells in a preclinical model of subpial cortical injury
Defining distinct features of anti-MOG antibody associated central nervous system demyelination - Martin S. Weber, Tobias Derfuss, Imke Metz, Wolfgang Brück, 2018
